In a statement, the company, Hospira, said that they have never condoned the use of their drug, marketed as 'Pentothal', in executions, and that they could not "prevent the drug from being diverted to departments of corrections for use in capital punishment procedures".
発表によると、ホスピラ社は製品名「ペントタール」の死刑執行の際の使用を容認したことはないと述べ、また「重大な懲罰過程で薬品が正しく使われる部門向けに供給を転向することができなかった」とも述べた。